Magnetic Duodeno-Ileal Bypass with Sleeve (MagDI + Sleeve)

Overview
Magnetic Duodeno‑Ileal Bypass with Sleeve (MagDI + Sleeve) is an emerging metabolic procedure that combines sleeve gastrectomy with a magnet‑assisted duodeno‑ileal bypass. It is designed to enhance metabolic effect beyond sleeve alone while preserving anatomy and reducing surgical complexity compared to traditional DS or SADI‑S.
How the Procedure Works
MagDI + Sleeve works by reducing stomach volume through sleeve gastrectomy and diverting nutrient flow to the ileum using a magnet‑assisted anastomosis, stimulating powerful incretin release, improving insulin sensitivity, and altering bile acid circulation to enhance metabolic outcomes.
Benefits
Potential benefits include improved metabolic effect compared to sleeve alone, enhanced GLP‑1 and PYY stimulation, preserved anatomy, lower surgical complexity than DS or SADI‑S, and an emerging option for patients seeking metabolic enhancement without traditional malabsorptive bypass.
Who Is a Candidate
Candidates may include patients with BMI ≥ 35, BMI 30–34.9 with metabolic disease, inadequate metabolic response to sleeve gastrectomy, or type 2 diabetes requiring enhanced metabolic effect beyond sleeve alone. Patient selection is individualized based on anatomy and metabolic goals.
How the Procedure Is Performed
The procedure begins with a standard sleeve gastrectomy. Magnets are then placed on the duodenum and a loop of ileum to create a controlled duodeno‑ileal bypass without traditional suture or staple anastomosis. The magnet‑assisted connection is designed to enhance metabolic signaling.
Limb lengths are determined by magnet placement and patient anatomy. The bypass configuration is designed to maximize metabolic effect while minimizing nutritional risk.
Risks and Considerations
Potential risks include bleeding, leak, stricture, bile reflux, nutritional deficiencies, magnet migration or device‑related complications, and weight regain. As an emerging procedure, long‑term safety and efficacy data are still accumulating.
Recovery Timeline
Days 1–3: hydration, gentle movement, pain control. Week 1: clear to full liquids. Week 2: soft foods. Weeks 3–4: transition to normal routines. By 30 days: improved energy and early metabolic changes. Nutritional follow‑up begins immediately.
Long-Term Expectations
Early studies show promising metabolic improvements and weight‑loss outcomes. Long‑term data are still accumulating. Lifelong nutritional follow‑up, supplementation, and lab monitoring are recommended.
Why Choose Dr. de la Cruz-Muñoz
Dr. Nestor de la Cruz‑Muñoz is a nationally recognized bariatric and metabolic surgeon with outcomes that exceed national benchmarks. His high‑volume experience, advanced minimally invasive techniques, and long‑term metabolic support model ensure safe, effective, and compassionate care.
Total Body Weight Loss (TBWL) Expectations
No BMI‑stratified 1‑year TBWL data exist for MagDI + Sleeve. Early studies show meaningful weight loss and metabolic improvement beyond sleeve alone. Results are expected to approach SADI‑S as long‑term data emerge.
Expected Metabolic Improvements
MagDI + Sleeve enhances metabolic effect through increased GLP‑1 and PYY release, improved insulin sensitivity, and bile acid pathway modulation. Early data suggest meaningful improvement in type 2 diabetes, hypertension, and dyslipidemia beyond sleeve alone.
MagDI + Sleeve may be preferred for patients seeking enhanced metabolic effect beyond sleeve without the full complexity of SADI‑S or DS.
Weight Regain Prevention Strategy
Potential long‑term issues include bile reflux, vitamin deficiencies, and anastomotic or device‑related complications. As an emerging procedure, surveillance protocols are evolving. Lifelong nutritional follow‑up and lab monitoring are recommended.
GERD / Reflux Considerations
Because the procedure includes a sleeve component, reflux may worsen in some patients. Patients with severe pre‑existing GERD should be evaluated carefully. The duodeno‑ileal bypass component may alter bile acid circulation and affect reflux symptoms.
Revision Options
MagDI + Sleeve may be considered for patients with inadequate metabolic response to sleeve gastrectomy. If further metabolic enhancement is needed, conversion to SADI‑S or DS remains an option. Long‑term revision data are still accumulating.
Body Composition & Muscle Preservation
Insurance & Qualification Requirements
As an emerging procedure, MagDI + Sleeve may not be covered by all insurers. Coverage varies by plan and medical necessity. Our team assists with verification and authorization.
Preparing for Surgery (Pre-Op Requirements)
Post-Op Nutrition Overview
Post-Op Activity & Exercise Guidance
Special Considerations for International Patients
Quick Procedure Details
Coverage varies due to emerging status. Verification required.







.webp)

